Cite
HARVARD Citation
Papatheodoridis, G. et al. (2017). The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B. Hepatology. 66 (5), pp. 1444-1453. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Papatheodoridis, G. et al. (2017). The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B. Hepatology. 66 (5), pp. 1444-1453. [Online].